TY - JOUR
T1 - Antimicrobial Prophylaxis in Surgical Patients
AU - Crossley, Kent B
AU - Gardner, Linda Couch
PY - 1981/2/20
Y1 - 1981/2/20
N2 - The use of antibiotic prophylaxis was prospectively evaluated in 1,021 surgical patients from 27 hospitals in metropolitan Minnesota. The majority of patients had undergone general surgical (23%), obstetric and gynecologic (13%), orthopedic (26%), and urologic (12%) procedures. One half of the courses of antibiotic prophylaxis were given to patients undergoing clean (class 1) surgery. Antibiotics were first administered in the four hours preceding the start of surgery in only 41% of the patients. The mean duration of prophylaxis was 3.4 days. About one third of the patients received prophylaxis for more than 72 hours; this group accounted for 65% of patient-days of antibiotic administration. More than one half of the patients received a cephalosporin. Analysis of patient charges suggests that 18% to 50% of the cost of perioperative antibiotic prophylaxis might be saved by limiting the duration of drug administration.
AB - The use of antibiotic prophylaxis was prospectively evaluated in 1,021 surgical patients from 27 hospitals in metropolitan Minnesota. The majority of patients had undergone general surgical (23%), obstetric and gynecologic (13%), orthopedic (26%), and urologic (12%) procedures. One half of the courses of antibiotic prophylaxis were given to patients undergoing clean (class 1) surgery. Antibiotics were first administered in the four hours preceding the start of surgery in only 41% of the patients. The mean duration of prophylaxis was 3.4 days. About one third of the patients received prophylaxis for more than 72 hours; this group accounted for 65% of patient-days of antibiotic administration. More than one half of the patients received a cephalosporin. Analysis of patient charges suggests that 18% to 50% of the cost of perioperative antibiotic prophylaxis might be saved by limiting the duration of drug administration.
UR - http://www.scopus.com/inward/record.url?scp=0019499152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019499152&partnerID=8YFLogxK
U2 - 10.1001/jama.1981.03310320044024
DO - 10.1001/jama.1981.03310320044024
M3 - Article
C2 - 6780702
AN - SCOPUS:0019499152
SN - 0098-7484
VL - 245
SP - 722
EP - 726
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 7
ER -